First Time Loading...

Fulcrum Therapeutics Inc
NASDAQ:FULC

Watchlist Manager
Fulcrum Therapeutics Inc Logo
Fulcrum Therapeutics Inc
NASDAQ:FULC
Watchlist
Price: 7.13 USD 0.71% Market Closed
Updated: May 1, 2024

Fulcrum Therapeutics Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fulcrum Therapeutics Inc
Cash from Financing Activities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Fulcrum Therapeutics Inc
NASDAQ:FULC
Cash from Financing Activities
$118.1m
CAGR 3-Years
18%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Cash from Financing Activities
-$15.8B
CAGR 3-Years
-32%
CAGR 5-Years
3%
CAGR 10-Years
-7%
Bristol-Myers Squibb Co
NYSE:BMY
Cash from Financing Activities
-$9.4B
CAGR 3-Years
-101%
CAGR 5-Years
-22%
CAGR 10-Years
-24%
Pfizer Inc
NYSE:PFE
Cash from Financing Activities
$26.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Cash from Financing Activities
-$4.8B
CAGR 3-Years
-19%
CAGR 5-Years
18%
CAGR 10-Years
2%
Eli Lilly and Co
NYSE:LLY
Cash from Financing Activities
$3.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Fulcrum Therapeutics Inc's Cash from Financing Activities?
Cash from Financing Activities
118.1m USD

Based on the financial report for Dec 31, 2023, Fulcrum Therapeutics Inc's Cash from Financing Activities amounts to 118.1m USD.

What is Fulcrum Therapeutics Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
2%

Over the last year, the Cash from Financing Activities growth was 40%. The average annual Cash from Financing Activities growth rates for Fulcrum Therapeutics Inc have been 18% over the past three years , 2% over the past five years .